Format of Initial Disclosure to be made by an entity identified as a Large Corporate.
| Sr. No. | Particulars | Details |
| 1 | Name of Company | Transgene Biotek Ltd |
| 2 | CIN NO. | L85195TG1990PLC011065 |
| 3 | Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) | 0.00 |
| 4 | Highest Credit Rating during the previous FY | 0 |
| 4a | Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4) | Not Applicable |
| 5 | Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the framework | BSE |
We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No
Name of the Company Secretary: ANKITA JAIN
Designation: COMPLIANCE OFFICER AND COMPANY SECRETARY
EmailId: cs@transgenebiotek.com
Designation: COMPLIANCE OFFICER AND COMPANY SECRETARY
EmailId: cs@transgenebiotek.com
Name of the Chief Financial Officer: PRASAD CHOWDARY
Designation: CFO
EmailId: accounts@transgenebiotek.com
Designation: CFO
EmailId: accounts@transgenebiotek.com
Date: 13/04/2026
Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.